Role of troponin in patients with chronic kidney disease and suspected acute coronary syndromes: a systematic review.
By: Stacy SR, Suarez-Cuervo C, Berger Z, Wilson LM, Yeh HC, Bass EB, Michos ED.
In chronic kidney disease patients suspected of having acute coronary syndromes, troponin levels can aid in identifying patients with a poor prognosis, but the diagnostic utility is limited by varying estimates of sensitivity and specificity.
Read on Pubmed
Prognostic value of cardiac troponins in chronic kidney disease patients without a suspected acute coronary syndrome: a systematic review.
By: Michos ED, Wilson LM, Yeh HC, Berger Z, Suarez-Cuervo C, Stacy SR, Bass EB.
In chronic kidney disease patients without suspected acute coronary syndromes, troponin elevations were associated with worse prognosis.
Read on Pubmed
Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis.
By: Bloomfield GS, Yi SS, Astor BC, Kramer H, Shea S, Shlipak MG, Post WS.
This study concluded that, with the inclusion of cystatin C in the estimated glomerular filtration rate assessment, hypertension was an important predictor of chronic kidney disease progression in a multi-ethnic cohort with stage 3 of the disease.
Read on Pubmed
25-hydroxyvitamin D levels, race, and the progression of kidney disease.
By: Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P.
Low 25-hydroxyvitamin D, or 25(OH)D, levels are associated with development of end stage renal disease (ESRD), even after adjustment for multiple risk factors. Low 25(OH)D levels may account for a substantial proportion of the increased risk for ESRD experienced by black individuals.
Read on Pubmed
